Literature DB >> 19305726

Innovations in the Ethical Review of Health-Related Quality Improvement and Research: The Alberta Research Ethics Community Consensus Initiative (ARECCI).

Brad Hagen1, Maeve O'Beirne, Sunil Desai, Michael Stingl, Cathy Anne Pachnowski, Sarah Hayward.   

Abstract

The Alberta Research Ethics Community Consensus Initiative (ARECCI) is a unique Canadian initiative that addresses the ethical oversight of two main categories of health-related investigative projects: research and quality improvement (including quality assurance and program evaluation). ARECCI was formed as a result of discussions arising from health regions, health researchers and the Alberta Committee of Research Ethics Boards (REBs) Chairs, who all desired a clearer and more consistent approach to the ethical oversight of investigative health projects. The Alberta Heritage Foundation for Medical Research (AHFMR) established and supported ARECCI in 2003 in response to this need. ARECCI is unique in its ongoing efforts to bring together a wide-ranging group of stakeholders to develop consensus on a set of pragmatic recommendations and tools for the ethical review of research and quality improvement, and to get extensive consultation on those recommendations. This paper presents the ARECCI context and process, recommendations and tools produced by ARECCI and lessons learned from the ongoing ARECCI process.

Year:  2007        PMID: 19305726      PMCID: PMC2585461     

Source DB:  PubMed          Journal:  Healthc Policy        ISSN: 1715-6572


  24 in total

Review 1.  The quality improvement-research divide and the need for external oversight.

Authors:  E Bellin; N N Dubler
Journal:  Am J Public Health       Date:  2001-09       Impact factor: 9.308

2.  Differentiating quality improvement from research.

Authors:  Anita C Reinhardt; Leslie N Ray
Journal:  Appl Nurs Res       Date:  2003-02       Impact factor: 2.257

Review 3.  Mental health quality improvement: what about ethics?

Authors:  Jan Horsfall; Michelle Cleary
Journal:  Int J Ment Health Nurs       Date:  2002-03       Impact factor: 3.503

4.  Ethical conduct recommendations for quality improvement projects.

Authors:  Toni Layer
Journal:  J Healthc Qual       Date:  2003 Jul-Aug       Impact factor: 1.095

5.  Quality improvement and the need for IRB review.

Authors:  David R Nerenz; Patricia K Stoltz; Jack Jordan
Journal:  Qual Manag Health Care       Date:  2003 Jul-Sep       Impact factor: 0.926

6.  Quality improvement or research: a distinction without a difference?

Authors:  David Doezema; Mark Hauswald
Journal:  IRB       Date:  2002 Jul-Aug

7.  Research ethics paperwork: what is the plot we seem to have lost?

Authors:  Konrad Jamrozik
Journal:  BMJ       Date:  2004-07-31

8.  Ethical review of health promotion program evaluation proposals.

Authors:  Wilfreda E Thurston; Ardene Robinson Vollman; Michael M Burgess
Journal:  Health Promot Pract       Date:  2003-01

9.  When does quality improvement count as research? Human subject protection and theories of knowledge.

Authors:  J Lynn
Journal:  Qual Saf Health Care       Date:  2004-02

10.  Oversight of quality improvement: focusing on benefits and risks.

Authors:  Bernard Lo; Michelle Groman
Journal:  Arch Intern Med       Date:  2003-06-23
View more
  19 in total

1.  Avoiding Potential Medication Errors Associated with Non-intuitive Medication Abbreviations.

Authors:  Jonas Shultz; Lisa Strosher; Shaheen Nenshi Nathoo; Jim Manley
Journal:  Can J Hosp Pharm       Date:  2011-07

2.  Predictors of referral for neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer and changes in practice over time.

Authors:  Geoffrey T Gotto; Melissa A Shea-Budgell; M Sarah Rose; J Dean Ruether
Journal:  Can Urol Assoc J       Date:  2015 Jul-Aug       Impact factor: 1.862

Review 3.  Ethical issues in using data from quality management programs.

Authors:  David R Nerenz
Journal:  Eur Spine J       Date:  2009-04-14       Impact factor: 3.134

4.  An audit of referral and treatment patterns of high-risk prostate cancer patients in Alberta.

Authors:  Majed Alghamdi; Amandeep Taggar; Derek Tilley; Marc Kerba; Xanthoula Kostaras; Geoffrey Gotto; Michael Sia
Journal:  Can Urol Assoc J       Date:  2016 Nov-Dec       Impact factor: 1.862

5.  Oversight on the borderline: Quality improvement and pragmatic research.

Authors:  Jonathan A Finkelstein; Andrew L Brickman; Alexander Capron; Daniel E Ford; Adrijana Gombosev; Sarah M Greene; R Peter Iafrate; Laura Kolaczkowski; Sarah C Pallin; Mark J Pletcher; Karen L Staman; Miguel A Vazquez; Jeremy Sugarman
Journal:  Clin Trials       Date:  2015-09-15       Impact factor: 2.486

6.  Exposure to radiation and medical oncology training: A survey of Canadian urology residents and fellows.

Authors:  Amandeep S Taggar; Kevin Martell; Siraj Husain; Michael Peacock; Michael Sia; Geoffrey Gotto
Journal:  Can Urol Assoc J       Date:  2018-05-28       Impact factor: 1.862

7.  Assessing guideline impact on referral patterns of post-prostatectomy patients to radiation oncologists.

Authors:  Amandeep Taggar; Majed Alghamdi; Derek Tilly; Xanthoula Kostaras; Marc Kerba; Siraj Husain; Geoff Gotto; Michael Sia
Journal:  Can Urol Assoc J       Date:  2016 Sep-Oct       Impact factor: 1.862

8.  Low compliance with guidelines for re-staging in high-grade T1 bladder cancer and the potential impact on patient outcomes in the province of Alberta.

Authors:  Geoffrey T Gotto; Melissa A Shea-Budgell; J Dean Ruether
Journal:  Can Urol Assoc J       Date:  2016 Jan-Feb       Impact factor: 1.862

9.  Real-world adjuvant TAC or FEC-D for HER2-negative node-positive breast cancer in women less than 50 years of age.

Authors:  S Lupichuk; D Tilley; X Kostaras; A A Joy
Journal:  Curr Oncol       Date:  2016-06-09       Impact factor: 3.677

10.  Patient-centered approaches to targeting incomplete bowel preparations for inpatient colonoscopies.

Authors:  Lindsey Russell; Pamela Mathura; Amanda Lee; Raveena Dhaliwal; Narmin Kassam; Ali Kohansal
Journal:  Ann Gastroenterol       Date:  2021-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.